July 25, 2012
A New Jersey federal court unsealed a complaint Tuesday alleging Cyberonics Inc. violated the False Claims Act in its campaign to convince regulators and doctors that its nerve-stimulating therapy system could treat severe depression, costing states' insurance $75 million.